Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin Effects on EPCs in Type 2 Diabetes
NCT00968006Phase 4Completed
- Sponsor
- Università di Padova
- Start
- Oct 2009
- Primary completion
- Jan 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of sitagliptin in type 2 diabetes mellitus (T2DM), sponsored by Università di Padova. Started Oct 2009; status: completed.
02
Drugs
sitagliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00968006.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00968006.